本页面由Tiger Trade Technology Pte. Ltd.提供服务

Maze Therapeutics

29.60
+0.17000.58%
成交量:28.23万
成交额:830.79万
市值:16.35亿
市盈率:-11.76
高:29.76
开:29.27
低:28.33
收:29.43
52周最高:53.65
52周最低:13.28
股本:5,524.87万
流通股本:3,725.03万
量比:0.76
换手率:0.76%
股息:- -
股息率:- -
每股收益(TTM):-2.5172
每股收益(LYR):-3.0510
净资产收益率:-37.35%
总资产收益率:-21.79%
市净率:3.61
市盈率(LYR):-9.70

数据加载中...

2026/08/17

重要事件披露

Form 8-K - Current report
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/12

重要事件披露

Form 8-K - Current report
2026/04/22

重要事件披露

Form 8-K - Current report
2026/04/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]